🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Skeletal Dysplasia

A Natural History Study in Children With a Type II Collagen Disorder With Short Stature NCT05408715n/a2 sites📍 Paris📍 Madrid Innoskel · Tests: Natural History Study Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis NCT06440148n/a1 site📍 Lublin Medical University of Lublin · Tests: SCLEROSTIN Decoding the Genetic Landscape of Skeletal Diseases NCT05876416n/a1 site📍 Stockholm Karolinska Institutet A Study in Children With Achondroplasia NCT07301463n/a8 sites📍 Beijing📍 Guangzhou📍 Zhengzhou Abbisko Therapeutics Co, Ltd · Tests: No Interventions, complete a natural history observation of ACH for at least 6 months and up to 2 years Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease NCT02504879n/a1 site📍 Bethesda National Institute of Arthritis and Musculoskeletal and Ski… Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy) NCT05328050n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Registry Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction. NCT07654647NA1 site📍 Latakia Latakia University · Tests: Patient-specific titanium implants for facial reconstruction Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) NCT07062588Phase 226 sites📍 Phoenix📍 New Haven📍 Wilmington Angitia Incorporated Limited · Tests: AGA2115, Placebo Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases. NCT04880356n/a1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Tests: collection of data Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry NCT03231644n/a1 site📍 Bethesda Tovah Burstein Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD) NCT01668186n/a1 site📍 Montreal McGill University Health Centre/Research Institute of the M… Functional and Morphological Characterization of Multiple Osteochondromas Disorder NCT06703736n/a1 site📍 Bologna Istituto Ortopedico Rizzoli RCDP Natural History Study NCT04031287n/a1 site📍 Wilmington MED-LIFE DISCOVERIES LP Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia NCT07441876Phase 2, Phase 328 sites📍 Oakland📍 Wilmington📍 Chicago BioMarin Pharmaceutical · Tests: BMN 333, Vosoritide Injection [Voxzogo] Longitudinal Study of Neurodegenerative Disorders NCT03333200n/a1 site📍 Pittsburgh University of Pittsburgh · Tests: Palliative Care, Hematopoetic Stem Cell Transplantation Registry of Ollier Disease and Maffucci Syndrome NCT04134572n/a1 site📍 Bologna Luca Sangiorgi Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta NCT05419960n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Vestibular Assessment, Petrous bone Computed Tomography (CT), Magnetic Resonance Imaging (MRI) Achondroplasia Natural History Multicenter Clinical Study NCT02597881n/a1 site📍 Baltimore Johns Hopkins University Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) NCT07169279Phase 212 sites📍 Oakland📍 Baltimore📍 Madison QED Therapeutics, a BridgeBio company · Tests: Infigratinib is provided as a single dose of minitablets for oral administration, Infigratinib is provided as sprinkle … FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC NCT06788990Phase 2, Phase 3231 sites📍 Birmingham📍 Phoenix📍 La Jolla Bicara Therapeutics · Tests: Ficerafusp alfa, Pembrolizumab (KEYTRUDA®), Placebo A Study of TYRA-300 in Children With Achondroplasia: BEACH301 NCT06842355Phase 225 sites📍 Torrance📍 Aurora📍 Wilmington Tyra Biosciences, Inc · Tests: TYRA-300 0.125 mg/kg, TYRA-300 0.25 mg/kg, TYRA-300 0.375 mg/kg, TYRA-300 0.50 mg/kg, TYRA-300 0.625 mg/kg Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing NCT06749366n/a1 site📍 Bethesda Eunice Kennedy Shriver National Institute of Child Health a… Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome NCT00001727n/a1 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… Non-invasive Functional Assessment and Pathogenesis of Morquio A NCT05284006n/a1 site📍 Wilmington Nemours Children's Clinic · Tests: Imaging, gait analysis, growth, joint test, hearing test, questionnaire, etc. Salivary Biomarkers in Periodontal Disease Progression NCT07661784n/a1 site📍 Isparta Suleyman Demirel University · Tests: Saliva Sampling Registry of Osteogenesis Imperfecta NCT04115774n/a1 site📍 Bologna Luca Sangiorgi · Tests: bisphosphonates Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta NCT05927389NA2 sites📍 Montpellier📍 Toulouse University Hospital, Toulouse · Tests: Adapted Physical Activity program Data Collection of Patients With Rare Bone Diseases NCT05247645n/a1 site📍 Bologna Luca Sangiorgi Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients NCT05858606NA1 site📍 Montpellier University Hospital, Montpellier · Tests: Evaluation of the prevalence of truly (authentified) idiopathic short stature after multidisciplinary clinico-radiologi… Fibrous Dysplasia: An Epidemiological and Correlational Evaluation of Multimodal Data NCT07569731n/a1 site📍 Bologna Istituto Ortopedico Rizzoli
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy